You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Fluorescein for Sentinel Lymph Node Detection
SBC: VESTAN INC Topic: NCIDESCRIPTION (provided by applicant): In this Phase II STTR project, Vestan Medical Imaging, Inc. will complete the development and clinical evaluation of its proprietary formulation of a fluorescent drug and new medical devices for Sentinel Lymph Node (SLN) biopsy for the surgical treatment of melanoma and breast cancer. Vestan will partner with the University of Utah Huntsman Cancer Institute (HC ...
STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
Memory Care Partner
SBC: Proactive Memory Services Topic: NIADESCRIPTION provided by applicant THE MEMORY CARE NAVIGATOR A PROACTIVE GUIDE Memory loss is an increasing problem as our population ages causing a tremendous personal and societal toll in disability and cost Alzheimerandapos s disease AD the most common cause of dementia is the illness elderly Americans most fear and the only major illness with an increasing mortality rate Despite subs ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Production and Characterization of Human Immunoglobulin Producing Goats for Diagnostic Reagents and Therapeutics
SBC: SAB CAPRA, LLC Topic: NIAIDProject Summary/Abstract The ultimate goal of this phase II STTR proposal is to expand the capabilities of SABandapos;s diversitAb™ platform by continuing advanced development of Transchromosomic goats (TcGs). This will be accomplished by producing male and female goat endogenous immunoglobulin gene knockout cell lines that contain SAB Capraandapos;s human artificial chromosome (HAC) which encod ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma
SBC: THERATARGET, INC. Topic: 102SUMMARY This STTR Phase II proposal addresses the significant need for improved treatment options for patients with liver cancerthe fifth highest incidence of cancer in the worldBecause of the lack of symptomshepatocellular carcinomaHCCis detected at advanced stages inof casesfor which theyear survival rate isand atyears it isThe only curative option for advanced HCC is surgical liver resection an ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Clinical Text Automatic De-Identification to Support Large Scale Data Reuse and Sharing
SBC: Clinacuity, Inc Topic: 400The adoption of Electronic Health Record (EHR) systems is growing at a fast pace in the U.S., and this growth results in very large quantities of patient clinical data becoming available in electronic format with tremendous potential but an equally large concern for patient confidentiality breaches. Secondary use of clinical data is essential to fulfill the potential for high quality healthcare, i ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
Automated Problem and Allergy Lists Enrichment Based on High Accuracy Information Extraction from the Electronic Health Record
SBC: Clinacuity, Inc Topic: NCIDESCRIPTION provided by applicant Medical errors are recognized as the cause of numerous deaths and even if some are difficult to avoid many are preventable Computerized physician order entry systems with decision support have been proposed to reduce this risk of medication errors but these systems rely on structured and coded information in the electronic health record EHR Unfortunately ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer
SBC: THERATARGET, INC. Topic: NCIDESCRIPTION provided by applicant The purpose of this Phase II STTR project is to develop a polymeric system for the combination delivery of two antineoplastic agents gemcitabine and paclitaxel Based on the successful results of the STTR Phase I award this Phase II proposal details the rationale and research plan for the synthesis and evaluation of in vivo efficacy of two novel macromolecula ...
STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Development of Advanced Military Prosthetic Shoulder System
SBC: Sarcos Group LC Topic: A05161A new dual pump hydraulic supply designed to enable energetically autonomous exoskeleton robots will be developed, tested and demonstrated. This new hydraulic supply will be integrated with a high performance hydraulically actuated full body exoskeleton robot and used to test and demonstrate the overall performances of such systems. New control policies that include: (i) an assist mode, where the ...
STTR Phase II 2017 Department of DefenseSpecial Operations Command -
Multiplexed GPCR Characterization Using SPR
SBC: Carterra, Inc. Topic: NIMHDESCRIPTION (provided by applicant): The goal of this Phase II STTR project is to develop a real-time label-free biosensor that can analyze 96 samples at a time, compared to the 6 samples possible with current technologies. This platform will initially bedemonstrated with G-protein-coupled receptors (GPCRs) and antibodies. What both applications have in common is the need for higher- throughput se ...
STTR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health -
Homogeneous Mutation Scanning
SBC: IDAHO TECHNOLOGY Topic: N/ADESCRIPTION (provided by applicant): Our objective is to provide a homogeneous, closed-tube system for DNA mutation scanning on a high-throughput platform. For many complex genetic diseases, it is very difficult and expensive to screen for all possible mutations that may cause the disease. We propose a relatively simple solution. Certain dyes are compatible with PCR and can detect sequence alterat ...
STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health